HCPLive Network

New Agent Significantly Improves Progression-Free Survival in Patients With Advanced ER+ Breast Cancer

Combining the investigational PD 0332991 with letrozole as first-line therapy extended progression-free survival in women with advanced estrogen-receptor positive breast cancer.

Click here to view this article.


Further Reading
Women who survive breast cancer face a higher risk of depression that can linger and require antidepressants, according to a new study published online Oct. 27 in the Journal of Clinical Oncology
Combined biennial digital mammography and tomosynthesis screening is effective for women with dense breasts, according to a study published online Oct. 28 in Radiology.
Researchers have found that a simple blood test might help diagnose pancreatic cancer, one of the most deadly forms of the disease.
More Reading